HomeComparePTSH vs JNJ

PTSH vs JNJ: Dividend Comparison 2026

PTSH yields 200.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTSH wins by $119.34M in total portfolio value
10 years
PTSH
PTSH
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full PTSH calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PTSH vs JNJ

📍 PTSH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTSHJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTSH + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTSH pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTSH
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PTSH beats the other by $51,148,978.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTSH + JNJ for your $10,000?

PTSH: 50%JNJ: 50%
100% JNJ50/50100% PTSH
Portfolio after 10yr
$59.69M
Annual income
$30,088,462.03/yr
Blended yield
50.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PTSH
No analyst data
Altman Z
-592.1
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTSH buys
0
JNJ buys
0
No recent congressional trades found for PTSH or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTSHJNJ
Forward yield200.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$119.36M$20.0K
Annual income after 10y$60,176,096.29$827.78
Total dividends collected$112.49M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PTSH vs JNJ ($10,000, DRIP)

YearPTSH PortfolioPTSH Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$30,700$20,000.00$10,676$355.77+$20.0KPTSH
2$90,232$57,383.18$11,407$389.39+$78.8KPTSH
3$254,173$157,624.56$12,198$426.53+$242.0KPTSH
4$686,927$414,961.74$13,056$467.62+$673.9KPTSH
5$1,783,118$1,048,106.39$13,987$513.12+$1.77MPTSH
6$4,450,613$2,542,677.12$14,998$563.56+$4.44MPTSH
7$10,693,420$5,931,263.38$16,098$619.52+$10.68MPTSH
8$24,760,608$13,318,648.86$17,295$681.69+$24.74MPTSH
9$55,315,649$28,821,798.66$18,599$750.82+$55.30MPTSH
10$119,363,841$60,176,096.29$20,022$827.78+$119.34MPTSH

PTSH vs JNJ: Complete Analysis 2026

PTSHStock

PTS Inc., through its subsidiary, Navistar Logistics (UK) Limited, provides logistics and supply chain management services in the United Kingdom and internationally. It principally offers air freight, sea freight, and road haulage services; and customs clearance, storage, and fulfillment services. The company was incorporated in 1996 and is based in Burnsville, Minnesota.

Full PTSH Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PTSH vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTSH vs SCHDPTSH vs JEPIPTSH vs OPTSH vs KOPTSH vs MAINPTSH vs ABBVPTSH vs MRKPTSH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.